Crescita Therapeutics Inc.
CRRTF
$0.56
$0.00-0.85%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -834.10K | -510.00K | 546.70K | 576.80K | -649.40K |
| Total Depreciation and Amortization | 278.30K | 294.80K | 278.80K | 255.10K | 246.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 180.50K | 238.90K | -486.40K | -73.70K | -55.70K |
| Change in Net Operating Assets | 477.50K | 274.70K | 512.60K | -760.40K | 101.70K |
| Cash from Operations | 102.10K | 298.40K | 851.60K | -2.20K | -357.40K |
| Capital Expenditure | -12.90K | -36.60K | -596.10K | -122.90K | -46.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.10K | 96.80K | -- | -- | -- |
| Cash from Investing | 25.20K | 60.30K | -596.10K | -122.90K | -46.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -58.00K | -165.00K | -118.00K | -116.00K | -116.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 0.00 | -121.00K | -59.00K | -43.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -50.00K | -- | -- | -- |
| Cash from Financing | -41.70K | -154.20K | -173.50K | -126.50K | -110.80K |
| Foreign Exchange rate Adjustments | 10.10K | -11.50K | 8.00K | -4.30K | 2.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.60K | 193.00K | 90.00K | -255.90K | -512.10K |